SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Sets New 1-Year High – Here’s What Happened

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)’s share price hit a new 52-week high during trading on Wednesday . The stock traded as high as $70.66 and last traded at $70.42, with a volume of 8538 shares changing hands. The stock had previously closed at $69.80.

SPDR S&P Pharmaceuticals ETF Stock Performance

The company has a market capitalization of $506.45 million, a price-to-earnings ratio of 14.28 and a beta of 0.58. The business’s 50 day moving average is $64.75 and its 200 day moving average is $59.38.

Institutional Investors Weigh In On SPDR S&P Pharmaceuticals ETF

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Western Wealth Management LLC acquired a new position in SPDR S&P Pharmaceuticals ETF in the 1st quarter worth approximately $34,000. Bank of America Corp DE increased its stake in shares of SPDR S&P Pharmaceuticals ETF by 128.0% in the first quarter. Bank of America Corp DE now owns 811,939 shares of the company’s stock worth $43,918,000 after acquiring an additional 455,802 shares during the period. Royal Bank of Canada raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 50.0% during the first quarter. Royal Bank of Canada now owns 40,649 shares of the company’s stock worth $2,199,000 after purchasing an additional 13,551 shares during the last quarter. SummitTX Capital L.P. acquired a new position in SPDR S&P Pharmaceuticals ETF during the first quarter valued at $843,000. Finally, First Citizens Bank & Trust Co. lifted its position in SPDR S&P Pharmaceuticals ETF by 0.7% during the first quarter. First Citizens Bank & Trust Co. now owns 187,397 shares of the company’s stock valued at $10,136,000 after purchasing an additional 1,393 shares during the period.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.